Skip to main content
Image
Graphs showing changes in primary and histopathological, endoscopic, and symptomatic secondary endpoints by treatment group.

Dupilumab Improves Outcomes for Individuals with Eosinophilic Gastritis

June 25, 2026
A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers shows that dupilumab improves outcomes in eosinophilic gastritis.

View News by Topic

Recent Articles

FacebookTwitter ShareLinkedIn ShareEmail Share